PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Indicated as a therapeutic compound for pain [PMID:33332000]; may block or inhibit the transmission of nervous impulses for pain control [PMID:28548193].
Cannabinoids and terpenes (e.g., $\beta$-caryophyllene, limonene, myrcene) exhibit antitumor effects by inducing apoptosis and inhibiting cell proliferation and angiogenesis [PMID:37238634].
Cannabinoids and terpenes have shown activity against pathogenic bacteria and fungus [PMID:33822478].
Supplementation with 10 g/30 kg body weight of fresh leaves maintained blood parameters (neutrophils, electrolytes, lymphocytes, and hemoglobin) during transit [PMID:38136918].
Indicated for anxiety, epilepsy, nausea, vomiting, and post-traumatic stress disorder [PMID:33332000].
Safety & adverse effects
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 33332000 (2021) — Constituents of Cannabis Sativa. · Advances in experimental medicine and biology
- 2.PMID: 34066753 (2021) — Cannabinoids, Phenolics, Terpenes and Alkaloids of Cannabis. · Molecules (Basel, Switzerland)
- 3.PMID: 34503268 (2021) — Cannabinoids and Cancer. · Cancers
- 4.PMID: 39769053 (2024) — Cannabis sativa: From Plants to Humans. · International journal of molecular sciences
- 5.PMID: 32668669 (2020) — The Antimicrobial Activity of Cannabinoids. · Antibiotics (Basel, Switzerland)